James P. Agalloco
James P. Agalloco
President,
Agalloco & Associates
Agalloco is a past president of the Parenteral Drug Association (PDA) and served as an officer or director of PDA from 1982 to 1993. He has authored or co-authored more than 90 papers and lectured extensively on sterilization, aseptic processing, and validation at various PDA, PMA, the International Society for Pharmaceutical Engineering (ISPE), and Pharmaceutical Technology meetings, domestically as well as internationally. He is a member of USP’s Microbiology and Sterility Assurance Expert Committee for 2005–2010. Agalloco is a member of the editorial advisory boards of Pharmaceutical Technology and Pharmaceutical Manufacturing, and serves on the scientific advisory boards of Laureate, MEDInstill, MODA, and IPS.
He is a frequent author and lecturer on the subject of sterilization, aseptic processing, and process validation.
James Agalloco is president of Agalloco & Associates, which provides a range of technical services to the pharmaceutical and biotechnology industry. Since the formation of the company in 1991, Agalloco has assisted more than 100 healthcare firms in a wide range of validation, automation and compliance areas. During his more than 35 years of industry experience, he has worked in organic synthesis, pharmaceutical formulation, pharmaceutical production, project and process engineering, validation and process automation during his career at Merck, Pfizer, Squibb and Bristol-Myers Squibb.
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.